- |||||||||| tolvaptan / Generic mfg.
Trial completion date, Trial termination, Trial primary completion date: Tolvaptan for Patients With Acute Neurological Injuries (clinicaltrials.gov) - Sep 24, 2018 P=N/A, N=25, Terminated, Trial completion date: Mar 2016 --> Jan 2017 Trial completion date: Sep 2017 --> Sep 2016 | Withdrawn --> Terminated | Trial primary completion date: Jul 2017 --> Jul 2016; Major protocol revision needed, current project terminated after enrollment of 25 patients.
- |||||||||| Enrollment change, Trial completion date, Trial withdrawal: Protein Supplementation in Thiazide-induced Hyponatremia (clinicaltrials.gov) - Sep 10, 2018
P=N/A, N=0, Withdrawn, Trial completion date: Sep 2017 --> Sep 2016 | Withdrawn --> Terminated | Trial primary completion date: Jul 2017 --> Jul 2016; Major protocol revision needed, current project terminated after enrollment of 25 patients. N=40 --> 0 | Trial completion date: Dec 2018 --> May 2018 | Recruiting --> Withdrawn
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Beer for Endurance Exercise Recovery (clinicaltrials.gov) - Apr 26, 2018
P=N/A, N=43, Completed, N=40 --> 0 | Trial completion date: Dec 2018 --> May 2018 | Recruiting --> Withdrawn Enrolling by invitation --> Completed | N=1000 --> 43 | Trial completion date: May 2019 --> May 2017 | Trial primary completion date: May 2019 --> May 2017
- |||||||||| tolvaptan / Generic mfg.
Enrollment change, Trial withdrawal: Tolvaptan for Patients With Acute Neurological Injuries (clinicaltrials.gov) - Nov 20, 2017 P=N/A, N=0, Withdrawn, Recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 69 N=80 --> 0 | Recruiting --> Withdrawn
- |||||||||| Trial primary completion date: Comparison of Infusion Methods for Hysteroscopic Procedures (clinicaltrials.gov) - Feb 10, 2017
P=N/A, N=100, Recruiting, N=80 --> 58 | Recruiting --> Terminated | Trial primary completion date: Apr 2017 --> Jan 2017 Trial primary completion date: Dec 2016 --> Jun 2017
- |||||||||| Enrollment open, Trial initiation date, Trial primary completion date: Protein Supplementation in Thiazide-induced Hyponatremia (clinicaltrials.gov) - Jun 18, 2016
P=N/A, N=40, Recruiting, Trial primary completion date: Jun 2016 --> Sep 2016 Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> Jun 2016 | Trial primary completion date: Dec 2017 --> May 2018
- |||||||||| Trial primary completion date: Comparison of Infusion Methods for Hysteroscopic Procedures (clinicaltrials.gov) - Feb 24, 2016
P=N/A, N=40, Recruiting, N=80 --> 4 | Suspended --> Terminated | Trial primary completion date: Feb 2016 --> Jan 2014; Enrollment goals were not met. Trial primary completion date: Dec 2015 --> Dec 2016
- |||||||||| tolvaptan / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: Fractional Urate Excretion in Nonedematous Hyponatremia (clinicaltrials.gov) - Dec 12, 2015 P=N/A, N=0, Withdrawn, Initiation date: Sep 2015 --> Dec 2015 N=20 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Nov 2013 --> Dec 2014
- |||||||||| Preclinical, Enrollment change, Trial termination, Trial primary completion date: Hyponatremia and Myometrium Contractility. An Invitro Study (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=12, Terminated, Not yet recruiting --> Enrolling by invitation N=30 --> 12 | Recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Oct 2015; Few biopsies showed the expected pattern We suspect erroeneous method.
- |||||||||| ibuprofen / Generic mfg.
Enrollment open, Trial primary completion date: NAKED: Non-steroidal Anti-inflammatory Affect on Kidneys in Endurance Distances (clinicaltrials.gov) - Aug 28, 2015 P3, N=120, Recruiting, N=30 --> 12 | Recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Oct 2015; Few biopsies showed the expected pattern We suspect erroeneous method. Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2015 --> Mar 2016
- |||||||||| Enrollment change, Trial initiation date, Trial withdrawal: Frequency and Origin of Dysnatremias in the Emergency Department (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=0, Withdrawn, Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2015 --> Mar 2016 N=200 --> 0 | Initiation date: Aug 2012 --> Oct 2011 | Not yet recruiting --> Withdrawn
- |||||||||| tolvaptan / Generic mfg.
Trial completion, Phase classification, Enrollment change, Trial primary completion date: OASIS: Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia (clinicaltrials.gov) - Aug 11, 2015 P3, N=98, Completed, N=200 --> 0 | Initiation date: Aug 2012 --> Oct 2011 | Not yet recruiting --> Withdrawn Recruiting --> Completed | Phase classification: PN/A --> P3 | N=296 --> 98 | Trial primary completion date: Nov 2013 --> Sep 2014
|